76 ShuklaT.KumarS.KhareR.TripathiR
Eide FF, Vining ER, Eide BL, Zang KL, Wang XY, Reichardt LF (1996)
doi: 10.1016/j.abb.2018.11.022 71
Tirzepatide (10mg-30mg), Dual-Action Incretin Co-Agonist Engineered Engagement of GIP and GLP-1 Receptors Introduction Engineered Engagement of GIP and GLP-1 Receptors Tirzepatide is a 39-residue synthetic peptide engineered to simultaneously activate two distinct incretin receptors, the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R), within a single molecular scaffold
1 Introduction Acetaminophen (APAP), also called paracetamol, is one of the most widely used analgesic and antipyretic over-the-counter drugs in the world (Lee, 2008